Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Revolution Medicines Inc (NQ: RVMD ) 46.77 -1.17 (-2.44%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Revolution Medicines Inc < Previous 1 2 3 4 Next > Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter July 16, 2024 Via Benzinga Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday July 16, 2024 Via Benzinga Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 09, 2024 Via Benzinga Revolution Medicines Inc. (NASDAQ: RVMD) Climbs to New 52-Week High April 10, 2024 Via Investor Brand Network Revolution Medicines's Earnings: A Preview February 23, 2024 Via Benzinga What 6 Analyst Ratings Have To Say About Revolution Medicines November 07, 2023 Via Benzinga Earnings Scheduled For November 6, 2023 November 06, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. Via Benzinga Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday July 09, 2024 Via Benzinga The 7 Most Undervalued Under-$50 Stocks to Buy in June 2024 June 08, 2024 Undervalued stocks under $50 hold significant appeal, but as every investor knows, value is in the eye of the beholder Via InvestorPlace The 3 Most Undervalued Biotech Stocks to Buy in June 2024 June 04, 2024 https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate Via InvestorPlace RVMD Stock Earnings: Revolution Medicines Beats EPS for Q1 2024 May 08, 2024 RVMD stock results show that Revolution Medicines beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Top 3 Health Care Stocks That May Collapse In Q2 April 12, 2024 As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. Via Benzinga Preview: Revolution Medicines's Earnings November 03, 2023 Via Benzinga Why Revolution Medicines Stock Is Crashing Today October 23, 2023 Investors were disappointed by Revolution Medicines' data, presented at ESMO. Via The Motley Fool Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 10, 2024 Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. Via Benzinga What's Going On With Revolution Medicines Stock? April 10, 2024 Revolution Medicines announced the publication of a peer-reviewed research paper in "Cancer Discovery" detailing the discovery and preclinical to clinical translation for RMC-6236 on Monday. The... Via Benzinga Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday April 10, 2024 U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Morgan Stanley Maintains Equal-Weight Rating for Revolution Medicines: Here's What You Need To Know March 08, 2024 Via Benzinga Earnings Scheduled For February 26, 2024 February 26, 2024 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. Via Benzinga Uncovering Noteworthy Technical Analysis Findings for REVOLUTION MEDICINES INC (NASDAQ:RVMD). February 01, 2024 A technical analysis of REVOLUTION MEDICINES INC. Via Chartmill Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development December 15, 2023 These pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better. Via InvestorPlace 3 Biotech Stocks That Could Boom or Bust by 2025 November 16, 2023 Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday. Via InvestorPlace Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details November 16, 2023 Raymond James initiated coverage on Revolution Medicines Inc (NASDAQ: RVMD), noting that the October readout of RMC-6236 was compelling compared to historical SoC. Via Benzinga Crude Oil Falls Sharply; Apollomics Shares Plunge October 23, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded down 0.19% to 33,062.85 while the NASDAQ rose 0.80% to 13,088.09. The S&P... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session October 23, 2023 Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 23, 2023 Via Benzinga Nasdaq Turns Higher; Akumin Shares Jump October 23, 2023 U.S. stocks pared losses midway through trading, with the Nasdaq Composite gaining over 60 points on Monday. The Dow traded down 0.01% to 33,126.50 while the NASDAQ rose 0.54% to 13,054.00. The S&P 500... Via Benzinga Topics Stocks Exposures US Equities FMC, Li-Cycle Holdings, Okta And Other Big Stocks Moving Lower On Monday October 23, 2023 U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Here are some big stocks recording losses in today’s session. Via Benzinga Topics Stocks Exposures US Equities Revolution Medicines Crashes 39% On Lackluster Test Results In Cancer Treatment October 23, 2023 The results were "at best, in line" with expectations for lung and pancreatic cancer treatment. Via Investor's Business Daily Dow Falls Over 100 Points; Chicago Fed National Activity Index Increases In September October 23, 2023 U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, The Dow traded down 0.41% to 32,991.58 while the NASDAQ fell... Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.